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The 20th century witnessed some 
notable public health triumphs in 
America: improvements in the wa-
ter supply, further control of several 
infectious diseases through vaccines 
and antimicrobial drugs, and increases 
in life expectancy with enormous im-
provements in survival rates of moth-
ers and their infants. What made these 
improvements possible? For anyone 
who has ever wondered, this book is 
an excellent place to start looking for 
answers.
The stated purpose of the book is 
not to provide a comprehensive his-
tory of public health in America but to 
discuss 10 key public health advances 
of the 20th century. This is a broad 
objective in itself, which this volume 
richly achieves. The advances, origi-
nally chosen for MMWR (Morbidity 
and Mortality Weekly Report) in 1999, 
are each expanded into a section of the 
book: Control of Infectious Diseases, 
Control of Disease through Vacci-
nation, Maternal and Infant Health, 
Nutrition, Occupational Health, Fam-
ily Planning, Fluoridation, Vehicular 
Safety, Cardiovascular Disease, and 
Tobacco and Disease Prevention. 
The facts and ﬁ  gures are all there, 
of course, and they are generally very 
well presented and referenced. Infec-
tious diseases are well represented; 
their respective chapters are excellent 
and informative. But it would be a pity 
if the reader stopped there. A unique 
strength of the book is the pairing of 
these expository chapters with essays 
by social scientists and historians who 
explore aspects of the social or politi-
cal context. This combination makes 
it a book to savor. Experienced prac-
titioners having a hard day may be 
encouraged to learn that many public 
health triumphs we take for granted 
today (the apt title Silent Victories is 
from a 1923 lecture by C.-E.A. Win-
slow) were made possible only by he-
roic and sustained effort.
One theme that emerges is the im-
portance of coalitions, often including 
not only the medical community and 
health departments (and sometimes 
industry), but also activists, reform-
ers, and even ordinary citizens who 
became passionate about a cause. Get-
ting recognition and consensus within 
the medical community was essential, 
and not always easy, as in the develop-
ment of occupational health, or even 
pasteurization at ﬁ  rst.  Wolf’s  article, 
for example, notes that ensuring clean 
pasteurized milk required 30 years of 
effort, during which time many infants 
died. In trafﬁ  c safety, discussed by Al-
bert, the activists were often the ones 
who pushed government into taking ac-
tion. With regard to the more recent ef-
forts toward tobacco cessation, Brandt 
argues that the 1964 Surgeon General’s 
Report was a watershed comparable 
to John Snow’s work on cholera, as it 
developed the foundations not only for 
tobacco cessation but also for chronic 
disease epidemiology. 
But, of course, public health can-
not rest on these laurels. As Koplan 
and Thacker note in the Epilogue, 
public health in the coming century 
will face many challenges. Some are 
a continuation of 20th-century trends, 
such as emerging infectious diseases, 
healthy lifestyle choices, and ensur-
ing that basic public health measures 
are available globally. Others will be 
new, including the aging of large seg-
ments of the population. As this book 
demonstrates, one of the best ways to 
meet the new challenges may well be 
to fully appreciate how these past suc-
cesses were achieved.
Stephen S. Morse*
*Columbia University, New York, New York, 
USA
Address for correspondence: Stephen S. Morse, 
Department of Epidemiology and Center for 
Public Health Preparedness, Mailman School of 
Public Health, Columbia University, New York, 
NY 10032, USA; email: ssm20@columbia.edu
Emerging Viruses 
in Human 
Populations
Edward Tabor, editor
Elsevier, Amsterdam, 
the Netherlands, 2007
ISBN: 978-0-444-52074-6
Pages: 374; Price: US $94.95
With increasing international 
travel and globalization of the world’s 
economies, changing climates, and al-
tered human behavior and demograph-
ics, multiple viruses have emerged to 
occupy expanded ecologic niches, pro-
ducing disease syndromes in parts of 
the world where they had never before 
existed. Because most emerging viral 
diseases in humans in the 21st century 
have been zoonotic, Emerging Viruses 
in Human Populations focuses on this 
group of viruses. The resulting over-
view is a book useful for anyone inter-
ested in a diverse group of viral agents 
that have recently elicited novel dis-
ease syndromes in human populations 
around the world. This text does an 
excellent job of encompassing a wide 
variety of contact-transmitted enzootic 
viruses including severe acute respira-
tory syndrome–associated coronavi-
rus, Nipah and Hendra viruses, inﬂ  u-
enza virus, hantaviruses, monkeypox 
viruses, and vector-transmitted agents 
including Crimean-Congo hemor-
rhagic fever, dengue, West Nile, and 
Japanese encephalitis viruses. BOOKS & MEDIA
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Two especially informative chap-
ters, the ﬁ  rst and last, introduce sev-
eral emerging viral disease agents that 
affect humans. The authors provide a 
synthesis of factors that could be as-
sociated with the emergence of novel 
viral agents, such as environmental 
change, altered human demographics, 
and human behavior. They also dis-
cuss the deﬁ  ning mechanisms through 
which emerging viral disease can be 
identiﬁ  ed and monitored.
The text outlines basic virologic 
characterization such as replication 
strategy and the role of known viral 
proteins in viral pathogenesis, diag-
nostics, treatment, and vaccine avail-
ability. Additionally, it covers epide-
miology of agents, relative disease 
manifestation, and disease patterns 
identiﬁ  ed in human populations. My 
only criticism regarding this ﬁ  ne re-
source is the lack of a consistent level 
of information presented for each viral 
agent. In some cases, for example, ex-
tensive information was presented on 
the role of all known viral proteins in 
replication of the virus and how these 
proteins contribute to disease manifes-
tations. For other agents, the epidemi-
ology was highlighted with relatively 
no coverage of viral pathogenesis. 
Many of the chapters are easily 
readable by the general public, yet 
the level of detail within most of the 
sections makes this also an excellent 
reference text for research and public 
health professionals. I recommend this 
book for anyone interested in obtaining 
a broad perspective on the emergence 
of viral diseases that affect humans.
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I am pleased to recommend 
Francisella tularensis: Biology, 
Pathogenicity, Epidemiology, and 
Biodefense, published by Blackwell 
Publishing Limited on behalf of the 
New York Academy of Sciences. This 
book is a much-needed comprehen-
sive overview of recent research on 
the causative agent of tularemia, a 
potentially serious illness that occurs 
naturally in the United States. F. tula-
rensis is a marvel among vector-borne 
agents of infectious disease. It has a 
wide geographic distribution (cover-
ing most of the Northern Hemisphere) 
and can be transmitted through a vari-
ety of routes including 1) tick or insect 
bites; 2) handling of infected animals; 
3) contact with or ingestion of water, 
food, or soil; and 4) inhalation of con-
taminated aerosols. Indeed, F. tularen-
sis is notorious for infecting laboratory 
workers and is a potential bioterror-
ism agent. The bacterium includes 4 
biovars, with the pathogenic type A 
recently shown to consist of at least 
2 subtypes in North America. Natural 
transmission cycles of F. tularensis are 
complex and poorly understood. 
Research on a broad variety of 
topics was carried out between the 
1914 recognition of F. tularensis as 
a disease agent in humans and the 
1970s, but few studies focused on this 
pathogen during the 1980s and 1990s. 
The recent designations of F. tularen-
sis by the National Institute of Allergy 
and Infectious Diseases as a priority 
A pathogen and a potential bioterror-
ism agent has resulted in an explo-
sion of new studies on this intrigu-
ing pathogen. Primary focal points 
of these studies have included vac-
cine development, improved patho-
gen detection methods, evaluation of 
the genetic variability of F. tularensis 
biovars commonly associated with 
human disease, description of the F. 
tularensis genome, and determination 
of virulence factors. The wealth of in-
formation gained from recent studies 
is elegantly outlined by an impressive 
group of world leaders in the ﬁ  eld of 
tularemia research. Chapter topics 
vary from molecular epidemiology, 
evolution, and ecology of Francisella 
to genetics, genomics, and proteomics 
of F. tularensis, molecular and ge-
netic basis of pathogenesis of F. tula-
rensis, animal models, immunity and 
immunopathogenesis, diagnosis and 
therapy, vaccine development, and 
biosafety issues.
Reﬂ  ecting a disturbing paucity of 
epidemiologic and ﬁ  eld-oriented stud-
ies in the past 20 years, especially in 
North America, only a few chapters 
include some information on epide-
miology, natural transmission cycles 
of F. tularensis, and the role of differ-
ent transmission routes to humans. As 
the ﬁ  eld of F. tularensis and tularemia 
research moves forward in the 21st 
century, the explosion of knowledge 
related to genetics, immunology, and 
pathogenesis of F. tularensis needs to 
be complemented by renewed studies 
on natural transmission cycles, trans-
mission routes to humans, and epide-
miology. 
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